Stem Cells as Potential Candidates for Psoriasis Cell-Replacement Therapy
Open Access
- 20 October 2017
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (10) , 2182
Abstract
Recent years have seen considerable progress in explaining the mechanisms of the pathogenesis of psoriasis, with a significant role played in it by the hyper-reactivity of Th1 and Th17 cells, Treg function disorder, as well as complex relationships between immune cells, keratinocytes, and vascular endothelium. The effect of stem cells in the epidermis and stem cells on T cells has been identified and the dysfunction of various types of stem cells may be a prime cause of dysregulation of the inflammatory response in psoriasis. However, exploring these mechanisms in detail could provide a chance to develop new therapeutic strategies. In this paper, the authors reviewed data on the role played by stem cells in the pathogenesis of psoriasis and initial attempts at using them in treatment.Keywords
This publication has 94 references indexed in Scilit:
- Wharton’s Jelly-Derived Mesenchymal Stem Cells: Phenotypic Characterization and Optimizing Their Therapeutic Potential for Clinical ApplicationsInternational Journal of Molecular Sciences, 2013
- Microvesicles Derived from Human Umbilical Cord Wharton’s Jelly Mesenchymal Stem Cells Attenuate Bladder Tumor Cell Growth In Vitro and In VivoPLOS ONE, 2013
- Photo(chemo)therapy Reduces Circulating Th17 Cells and Restores Circulating Regulatory T Cells in PsoriasisPLOS ONE, 2013
- miR-155 regulates IFN-γ production in natural killer cellsBlood, 2012
- miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1Blood, 2011
- Mutator activity induced by microRNA-155 ( miR-155 ) links inflammation and cancerProceedings of the National Academy of Sciences, 2011
- Pro-Inflammatory Cytokines, IFNγ and TNFα, Influence Immune Properties of Human Bone Marrow and Wharton Jelly Mesenchymal Stem Cells DifferentiallyPLOS ONE, 2010
- Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodesBlood, 2009
- Amelioration of severe psoriasis with psoriatic arthritis for 20 years after allogeneic haematopoietic stem cell transplantationAnnals of the Rheumatic Diseases, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006